Two nights ago thunderstorms washed over us from midnight until almost sunrise. After our first delight and the open windows to let the wind blow through the house, we got grumpier by the half hour and wandered up and down the stairs checking for damage (none) and whenever we had settled down to catch up on sleep, it started anew.
Obviously, we were not in top form yesterday. Also, it got steamy and muggy hot, and before we knew it the sky was closing in with black clouds and not a breath of wind. We got a storm warning from the insurance app and I pulled the router plug seconds before the lightning started. I've experienced my share of thunder storms but this was massive incl. hail stones and water in sheets so dense you could not see through to the other side of our suburban street.
Today, I made apple sauce from the windfall apples that dropped from the neighbour's garden onto our back lane and cut R's hair, finally. The apple sauce is delicious but the haircut is messy.
On The Covid front, I'll cut and paste as my latest public service announcement from an excellent article by Garret FitzGerald, director of the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania (the bold markings are mine):
". . . the World Health Organisation estimates there are 165 vaccine programmes under way. This is unprecedented, as is the diversity of approaches to vaccine development. (. . .) Indeed, it is likely we will need more than one effective vaccine if we are to reach the numbers globally that are necessary for effective immunity.
Given the political, cultural, and logistical challenges, attaining the goal of population immunity of 60-80 per cent, necessary in our connected world, is likely to take some time, maybe years.Population protection in advanced societies with an assured supply of a vaccine by late summer 2021 is a reasonable bet.
Despite politically and commercially-driven promises that we will be protected from Covid-19 by vaccines early next year, this is extremely unlikely. Mass vaccination based on trials of a few thousand patients – as suggested in Russia – would be reckless.
Masks, distancing, and hand-washing will be the rule for the foreseeable future. In the meantime there is encouraging progress in the development of drugs to curb the severity of Covid-19 and this, as with AIDS, may lead us to a semblance of normality even sooner than an effective vaccine."
(You can read the complete article here.)